Koers Canntab Therapeutics Limited Canadian Securities Exchange
Aandelen
PILL
CA1377991023
Farmaceutische producten
Omzet 2021 | - | Omzet 2022 | 0,29 0,4 0,27 | Marktkapitalisatie | 9,99 mln. 13,67 mln. 9,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -4 mln. -5,48 mln. -3,74 mln. | Nettowinst (verlies) 2022 | -3 mln. -4,11 mln. -2,81 mln. | EV/omzet 2021 | - |
Nettoschuld 2021 | 75,05K 103K 70,21K | Nettoschuld 2022 | 1,15 mln. 1,57 mln. 1,08 mln. | EV/omzet 2022 | 37.969.265 x |
K/w-verhouding 2021 |
-7,9
x | K/w-verhouding 2022 |
-2,63
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 86,26% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,99% | 5,68 mld. | |
-31,99% | 3,61 mld. | |
-0,59% | 3,11 mld. | |
-24,15% | 2,65 mld. | |
-9,23% | 2,33 mld. | |
+42,55% | 1,89 mld. | |
+44,37% | 1,49 mld. | |
-11,29% | 1,46 mld. | |
+42,86% | 1,37 mld. |